OncoPharm cover image

Apalutamide

OncoPharm

00:00

Exploring Apalutamide: Efficacy, Safety, and Pharmacological Considerations

This chapter explores the approval of apalutamide for non-metastatic castrate-sensitive prostate cancer, detailing its mechanism of action and dosing. It also reviews the SPARTAN study results, drug interactions, side effects, and the critical role of pharmacists in patient monitoring.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app